Polar Pharma India Ltd.
BSE: 523333
₹0.82
₹-0.04
(-4.65%)
As on 17-Sep-2013IST
Market cap
₹1 Cr
Revenue (TTM)
₹16 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-19 Cr
-
ROE
0 %
-
ROCE
-20.3 %
-
Industry P/E
189.97
-
EV/EBITDA
-64.1
-
Debt to Equity
-1.2
-
Book Value
₹--
-
EPS
₹-16.6
-
Face value
10
-
Shares outstanding
12,270,729
10 Years Aggregate
CFO
₹-11.39 Cr
EBITDA
₹-12.18 Cr
Net Profit
₹-127.31 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Polar Pharma India
| -59.6 | -13.7 | -11.8 | -65.7 | -39.9 | -29.2 | -20.0 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Commodities#
| 9.7 | 2.7 | -1.2 | 13.5 | 16.4 | 9.7 | 14.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Polar Pharma India
|
0.8 | 1.0 | -- | -20.4 | -- | -- | -- | 0.0 |
| 227.0 | 256.1 | 94.1 | 8.0 | -- | 44.2 | 40.4 | 4.9 | |
| 68.0 | 47.8 | 80.3 | 4.0 | -- | 24.7 | 11.9 | 2.0 | |
| 169.9 | 170.4 | 182.1 | 6.2 | 4.3 | 16.6 | 27.5 | 4.2 | |
| 60.9 | 305.0 | 351.0 | -197.9 | -22.2 | -65.9 | -- | 7.5 | |
| 568.0 | 325.9 | 31.9 | 2.9 | -- | 22.4 | 58.3 | 16.5 | |
| 2,010.9 | 1,077.3 | 568.4 | 5.7 | 4.9 | 3.8 | 190 | 6.0 | |
| 128.0 | 249.8 | 49.4 | 10.5 | -- | 53.6 | 23.8 | 3.2 | |
| 86.0 | 83.7 | 31.1 | 1.5 | -- | 9.3 | 20.5 | 3.0 | |
| 68.6 | 368.4 | 591.1 | 25.7 | 4.8 | 8.3 | 14.3 | 1.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Polar Pharma India
Manufacture of rubber contraceptives
-
Incorporated
1988
-
Chairman
Anil Agarwal
-
Managing Director
Anil Agarwal
-
Group
Polar
-
Headquarters
Balasore Dist, Orissa
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Polar Pharma India
What is the current share price of Polar Pharma India Ltd Today?
The share price of Polar Pharma India Ltd is ₹0.82 (BSE) as of 17-Sep-2013 IST. Polar Pharma India Ltd has given a return of -39.86% in the last 3 years.
What is the current PB & PE ratio of Polar Pharma India Ltd?
Since, TTM earnings of Polar Pharma India Ltd is negative, P/E ratio is not available.
The P/B ratio of Polar Pharma India Ltd is -0.01 times as on 17-Sep-2013, a 100 discount to its peers’ median range of 5.96 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2012 |
0.00 |
-0.02 |
2011 |
0.00 |
-0.03 |
2010 |
0.00 |
-0.04 |
2009 |
0.00 |
-0.04 |
2008 |
0.00 |
10.62 |
What is the 52 Week High and Low of Polar Pharma India Ltd?
The 52-week high and low of Polar Pharma India Ltd are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Polar Pharma India Ltd?
Polar Pharma India Ltd has a market capitalisation of ₹ 1 Cr as on 17-Sep-2013. As per SEBI classification, it is a company.
Should I invest in Polar Pharma India Ltd?
Before investing in Polar Pharma India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.